---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-077596"
form_type: "8-K"
ticker: "MBIO"
cik: "0001680048"
company_name: "MUSTANG BIO, INC."
filed_at: "2024-07-03T23:59:59+00:00"
generated_at: "2026-05-31T23:30:24.978934+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Mustang Bio repurchases previously sold assets for $1.4M; shareholders approve reverse split and warrant share issuance

## Summary
- Company to repurchase assets from uBriGene for $1,395,138; $100K upfront, $1,295,138 deferred for 12 months with possible extensions.
- Shareholders approved issuance of up to 60,731,608 shares underlying warrants, representing over 20% of outstanding common stock.
- Shareholders also authorized a reverse stock split between 1-for-10 and 1-for-50, with Board to determine exact ratio.
- Repurchase is an Expedited Divestment under CFIUS National Security Agreement signed May 13, 2024, reversing the prior sale.
- Company may defer deferred payment if net assets fall below $20M; unpaid amounts accrue 5% interest after 12 months.

## SEC filing metadata
- accession: 0001104659-24-077596
- form_type: 8-K
- ticker: MBIO
- cik: 0001680048
- company_name: MUSTANG BIO, INC.
- filed_at: 2024-07-03T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 1.02, 2.01, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1680048/000110465924077596/0001104659-24-077596-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1680048/000110465924077596/tm2418844d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-077596
- JSON: https://secwatch.observer/filing/0001104659-24-077596.json
- Plain text: https://secwatch.observer/filing/0001104659-24-077596.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.